From: Dose-dependent effect of canine lyophilized platelet on an in vitro hemodilution model
Control | Group 1 | Group 2 | Group 3 | ||
---|---|---|---|---|---|
Fibrinogen (mg/dl) | 76 (55–89) | 78 (63–94) | 77 (62–97) | 81 (60–96) | |
PT (sec) | 9.05 (8.6–9.3) | 9.1 (8.7–9.5) | 9.15 (8.8–9.5) | 9.05 (8.9–9.4) | |
aPTT (sec) | 32.5 (28.9–37.0) | 27 (25.1–32.4) | 24.6 (21.9–27.3)* | 24.7 (19.3–30.3)* | |
TEG | R time (min) | 4.1 (2.8–5.2) | 2.15 (1.5–2.8)* | 1.8 (1.1–2.5)* | 1.75 (1.3–2.1)* |
K time (min) | 0 | 0 (0-7.8) | 0 (0-4.5) | 3.5 (0–7) | |
Angle (°) | 34.3 (21.1–58.3) | 49.7 (37.1–67.1)* | 54.5 (44.3–70)* | 54.7 (42.6–64.6)* | |
MA (mm) | 8.7 (3.1–16.1) | 11.2 (6.1–23.4) | 15.4 (10-24.6)* | 25.2 (172 − 31.5)*# | |
Ct (sec) | 210 (139–287) | 169 (131–219) | 160 (139–195) | 145 (118–162)* |